Katie Istomin
Katie Istomin
Event Name: Battle for Gold
Location: Gold Ribbon Riders Teen Initiative
I’m raising money with Cycle for Survival, the movement to beat rare cancers. Will you donate and help me make a difference?
Since 2007, the Cycle for Survival community has enabled hundreds of doctors and scientists at Memorial Sloan Kettering Cancer Center (MSK) to pursue bold ideas aimed at transforming rare cancer treatment. Funding from Cycle for Survival has led to the FDA approval of new drugs, lifesaving clinical trials, and state-of-the-art DNA sequencers that are aiding in key cancer breakthroughs.
Your gift today can give people with a rare cancer a better future.
50% of People With Cancer Have a Rare Cancer
About half of all people with cancer have a rare form of the disease. Rare cancers include many types you’ve likely heard of, such as leukemia and lymphoma, thyroid, ovarian, brain, and pancreatic cancers, as well as all pediatric cancers.
100% of Your Donation Supports Research.
It is often challenging to secure funding for rare cancer research, which is why support from Cycle for Survival is so crucial. Every dollar you give will go directly to innovative research and clinical trials at MSK. Discoveries made at MSK revolutionize how cancer is diagnosed and treated, benefiting people worldwide.
Thank you for your generosity. Together, we will beat rare cancers.
![](../images/friendraiser_uploads/1414628954.custom.jpg)
Goal
The Cycle for Survival Web page and e-mail are provided as a courtesy to participants to help them manage fundraising efforts for this event. Memorial Sloan Kettering Cancer Center or any of its affiliated organizations, or their officers, directors, agents, or employees do not control, nor are they responsible for, the contents of this Web page. Any views or information provided on this Web page are the sole responsibility of the participant. The participant's Web page may provide links to other Web sites and does not imply an endorsement by MSKCC, its affiliated organizations, their officers, directors, agents, and employees of the materials contained at those Web sites. |